These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28978604)

  • 1. Oxaliplatin-induced posterior reversible encephalopathy syndrome (PRES).
    Janjua TK; Hassan M; Afridi HK; Zahid NA
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin and a fluoropyrimidine: a case report and literature review.
    Femia G; Hardy TA; Spies JM; Horvath LG
    Asia Pac J Clin Oncol; 2012 Jun; 8(2):115-22. PubMed ID: 22524570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior reversible encephalopathy syndrome: A rare neurotoxicity after capecitabine.
    Monti M; Barone D; Amadori E; Bartolini G; Ruscelli S; Frassineti GL
    J Oncol Pharm Pract; 2020 Oct; 26(7):1795-1801. PubMed ID: 32312144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin-induced posterior reversible encephalopathy syndrome with isolated involvement of pons.
    Tang KH
    J Cancer Res Ther; 2015; 11(4):1022. PubMed ID: 26881576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capecitabine-induced posterior reversible encephalopathy syndrome (PRES) in a patient with gastric adenocarcinoma.
    Dirani K; Marusca G; Wang J; Juzych D
    BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 38035676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior Reversible Encephalopathy Syndrome (PRES) Presenting as Status Epilepticus: A Case Report and Literature Review.
    Sharma P; Abbas MK; Huynh M
    Conn Med; 2016 Sep; 80(8):475-478. PubMed ID: 29782783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior Reversible Encephalopathy Syndrome after a Variety of Combined Chemotherapies Containing Bevacizumab for Metastatic Colon Cancer.
    Katada E; Mitsui A; Sasaki S; Uematsu N; Anan C
    Intern Med; 2018 Aug; 57(16):2403-2407. PubMed ID: 29526944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blindness and symmetrical neurological deficit in a patient with colon cancer receiving adjuvant chemotherapy: is it always cancer?].
    Leshem Y; Fennig S; Talianski E; Greenberg G; Wolf I
    Harefuah; 2014 Nov; 153(11):650-1, 687. PubMed ID: 25563024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed reversible posterior encephalopathy syndrome following chemotherapy with oxaliplatin.
    Sharief U; Perry DJ
    Clin Colorectal Cancer; 2009 Jul; 8(3):163-5. PubMed ID: 19632931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
    Tsuruta A; Yamashita K; Tanioka H; Tsuji A; Inukai M; Yamakawa T; Yamatsuji T; Yoshimitsu M; Toyota K; Yamano T; Nagasaka T; Okajima M
    Drug Des Devel Ther; 2016; 10():3827-3835. PubMed ID: 27920498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of colon cancer with reversible posterior leukoencephalopathy syndrome following 5-FU and oxaliplatin (FOLFOX regime)].
    Nagata Y; Omuro Y; Shimoyama T; Sasaki E; Okamoto R; Maeda Y; Kishida S; Sasaki T
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1163-6. PubMed ID: 19620809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.
    Singer S; Grommes C; Reiner AS; Rosenblum MK; DeAngelis LM
    Oncologist; 2015 Jul; 20(7):806-11. PubMed ID: 26032137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical PRES with diffusion restriction or neurotoxicity- ? part of same spectrum-after oxaliplatin (FOLFOX-4 regimen) for colonic cancer.
    Sen A; Jiji V; Roshni S; Prahladan A; Venugopal M; Ramachandran K
    Curr Probl Cancer; 2019 Dec; 43(6):100494. PubMed ID: 31320182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior reversible encephalopathy syndrome in the emergency department: A single center retrospective study.
    Miller R; Wagner S; Hammond J; Roberts N; Marshall K; Barth B
    Am J Emerg Med; 2021 Jul; 45():61-64. PubMed ID: 33667750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma.
    Chang Y; Mbeo G; Littman SJ
    J Gastrointest Cancer; 2012 Sep; 43(3):505-7. PubMed ID: 21556724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior reversible encephalopathy syndrome (PRES) after treatment with oxaliplatin and 5-fluorouracil.
    Truman N; Nethercott D
    Clin Colorectal Cancer; 2013 Mar; 12(1):70-2. PubMed ID: 22917935
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of oxaliplatin-related posterior reversible encephalopathy syndrome.
    Skelton MR; Goldberg RM; O'Neil BH
    Clin Colorectal Cancer; 2007 Jan; 6(5):386-8. PubMed ID: 17311705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent posterior reversible encephalopathy syndrome after chemotherapy in hematologic malignancy-posterior reversible encephalopathy syndrome can strike twice!!!
    Roy S; Gandhi AK; Jana M; Julka PK
    J Cancer Res Ther; 2014; 10(2):393-6. PubMed ID: 25022403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term consequences of the posterior reversible encephalopathy syndrome in eclampsia and preeclampsia: a review of the obstetric and nonobstetric literature.
    Postma IR; Slager S; Kremer HP; de Groot JC; Zeeman GG
    Obstet Gynecol Surv; 2014 May; 69(5):287-300. PubMed ID: 25101694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment.
    Godinho J; Casa-Nova M; Mesquita T; Baptista MJ; Araújo F; Vale J; Passos Coelho JL
    J Oncol Pharm Pract; 2019 Mar; 25(2):497-501. PubMed ID: 29121830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.